Výsledky vyhledávání - "Galina Baskhaeva"

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Autor: Andrey Sudarikov, K. I. Zarubina, B V Biderman, Andrey N. Sokolov, Vera V. Troitskaya, Galina Baskhaeva, Ekaterina Y. Demidova, Ekaterina S. Kotova, Valeriy G. Savchenko, Olga A. Gavrilina, V. L. Surin, Elena N. Parovichnikova, O. S. Pshenichnikova

Publikováno v: Blood. 136:9-10

CONTEXT:A substantial number of patients with acute lymphoblastic leukemia (ALL) die from progressive disease after relapse that is frequently associated with clonal evolution. Clinical exome sequencing (CES) is a useful tool for mutation investigati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f76d343b2380a532b8e72b0fcc2d3378
https://doi.org/10.1182/blood-2020-136041

Zobrazit plný text záznamu

Genetic Polymorphisms of TPMT and NUDT15 Genes and Thiopurine Treatment-Related Toxicity in Adult Patients with Acute Lymphoblastic Leukemia in Russia

Autor: Valeriy G. Savchenko, Vera V. Troitskaya, Olga A. Gavrilina, Andrey Sudarikov, Galina Baskhaeva, Igor Yakutik, Elena N. Parovichnikova, Ksenia Zarubina, Hunan Julhakyan, B V Biderman, Ekaterina S. Kotova

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 19:S191-S192

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7bf377ecf9b39f5ecbf690077c124046
https://doi.org/10.1016/j.clml.2019.07.036

Zobrazit plný text záznamu

The Type of BCR/ABL1 Fusion Transcript Does Not Affect Therapy Effectiveness of Ph-Positive Acute Lymphocytic Leukemia in the Era of Tyrosine Kinase Inhibitors in Russian Trial Ph+ALL

Autor: Galina Baskhaeva, Andrey N. Sokolov, Zalina T. Fidarova, Kseniya Zarubina, Mikhail Drokov, Tatyana Lobanova, Vera V. Troitskaya, Hunan Julhakyan, Valerii G. Savchenko, Elena N. Parovichnikova, Olga A. Gavrilina, Irina A. Lukianova

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 18:S186-S187

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e20a6dd22aab1de496ea585e2d5bc30
https://doi.org/10.1016/j.clml.2018.07.021

Zobrazit plný text záznamu

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Publikováno v: Blood. 134:5072-5072

Introduction. MRD-tailored therapy based on pediatric-inspired intensification is a back-bone of the majority of the European study groups in adult ALL. Taking in consideration the major pitfalls of the first Russian acute lymphoblastic leukemia stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6dedd102772a97f1d00c1af17225c70c
https://doi.org/10.1182/blood-2019-124701

Zobrazit plný text záznamu

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Publikováno v: Blood. 132:5185-5185

Introduction RALL-2009 study (NCT01193933) has demonstrated that non-intensive but non-interruptive treatment with fewer allo-HSCT is rather effective in adult Ph-negative ALL pts aged 18-55 yy, producing more than 50% OS at 8-years [Parovichnikova,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c402c55e3413e625b18ae4dfd81b69ff
https://doi.org/10.1182/blood-2018-99-116318

Zobrazit plný text záznamu

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Autor: Olga A. Gavrilina, Andrey N. Sokolov, K. I. Zarubina, Galina Baskhaeva, Vera V. Troitskaya, Elena N. Parovichnikova, Valery G. Savchenko, Larisa A. Kuzmina

Publikováno v: Blood. 128:2805-2805

Introduction. For more than a decade it's postulated that the addition oftyrosine kinase inhibitors (TKI) to chemotherapy has dramatically improved the long term outcome in Ph-positive adult acute lymphoblastic leukemia (Ph+ ALL). Nevertheless whethe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8ee6c0cb5db03ed658d4c203f7feb33
https://doi.org/10.1182/blood.v128.22.2805.2805

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání